Also known as آسٹیوپوروسس مینجمنٹ
Internal Medicine Specialist
M.B.B.S., F.C.P.S.
Endocrinologist
M.B.B.S., F.C.P.S., MRCP-SCE Endorinology & Diabetes (UK), Fellow FCPS Endocrinology & Diabetes, MRCP Medicine (Glasgow), MCPS (Family Medicine), M-ESSM (Europe), MACE (USA), MGAED (Gulf)
Endocrinologist
M.B.B.S., F.C.P.S., MRCP-SCE Endorinology & Diabetes (UK), Fellow FCPS Endocrinology & Diabetes, MRCP Medicine (Glasgow), MCPS (Family Medicine), M-ESSM (Europe), MACE (USA), MGAED (Gulf)
Internal Medicine Specialist
M.B.B.S, M.R.C.P. (UK)
Internal Medicine Specialist
M.B.B.S., F.C.P.S.
Consultant Physician
M.B.B.S, M.C.P.S, M.D
Bisphosphonates are used as first-line pharmacologictreatment for osteoporosis. In patients who cannot tolerate or whose symptoms do not improve with bisphosphonate therapy, teriparatide (Forteo) and denosumab (Prolia) are effective alternative medications to prevent osteoporotic fractures